| A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum A Roth, SP Maher, AJ Conway, R Ubalee, V Chaumeau, C Andolina, ... Nature communications 9 (1), 1837, 2018 | 150 | 2018 |
| Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies FB Ntumngia, J Schloegel, SJ Barnes, AM McHenry, S Singh, CL King, ... Infection and immunity 80 (3), 1203-1208, 2012 | 70 | 2012 |
| An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies FB Ntumngia, CV Pires, SJ Barnes, MT George, R Thomson-Luque, ... Scientific reports 7 (1), 13779, 2017 | 33 | 2017 |
| In-depth phenotypic characterization of reticulocyte maturation using mass cytometry R Thomson-Luque, C Wang, FB Ntumngia, S Xu, K Szekeres, A Conway, ... Blood Cells, Molecules, and Diseases 72, 22-33, 2018 | 30 | 2018 |
| Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II FB Ntumngia, J Schloegel, AM McHenry, SJ Barnes, MT George, ... Vaccine 31 (40), 4382-4388, 2013 | 27 | 2013 |
| Identification and characterization of functional human monoclonal antibodies to Plasmodium vivax duffy-binding protein LL Carias, S Dechavanne, VC Nicolete, S Sreng, S Suon, C Amaratunga, ... The Journal of Immunology 202 (9), 2648-2660, 2019 | 26 | 2019 |
| Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein AM McHenry, SJ Barnes, FB Ntumngia, CL King, JH Adams PloS one 6 (5), e20192, 2011 | 26 | 2011 |
| A rapid sensitive, flow cytometry-based method for the detection of Plasmodium vivax-infected blood cells W Roobsoong, SP Maher, N Rachaphaew, SJ Barnes, KC Williamson, ... Malaria Journal 13, 1-11, 2014 | 25 | 2014 |
| Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand P Chootong, T Panichakul, C Permmongkol, SJ Barnes, ... PloS one 7 (4), e35769, 2012 | 24 | 2012 |
| Insights into an Optimization of Plasmodium vivax Sal-1 In Vitro Culture: The Aotus Primate Model K Shaw-Saliba, R Thomson-Luque, N Obaldía III, M Nuñez, S Dutary, ... PLoS neglected tropical diseases 10 (7), e0004870, 2016 | 22 | 2016 |
| Identification of an immunogenic broadly inhibitory surface epitope of the Plasmodium vivax Duffy binding protein ligand domain MT George, JL Schloegel, FB Ntumngia, SJ Barnes, CL King, JL Casey, ... Msphere 4 (3), 10.1128/msphere. 00194-19, 2019 | 21 | 2019 |
| Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II FB Ntumngia, SJ Barnes, AM McHenry, MT George, J Schloegel, ... Clinical and Vaccine Immunology 21 (9), 1215-1223, 2014 | 20 | 2014 |
| An adaptable soft-mold embossing process for fabricating optically-accessible, microfeature-based culture systems and application toward liver stage antimalarial compound testing SP Maher, AJ Conway, A Roth, SR Adapa, P Cualing, C Andolina, ... Lab on a Chip 20 (6), 1124-1139, 2020 | 18 | 2020 |
| A simple and efficient method for cryopreservation and recovery of viable Plasmodium vivax and P. falciparum sporozoites N Singh, SJ Barnes, R Jenwithisuk, J Sattabongkot, JH Adams Parasitology international 65 (5), 552-557, 2016 | 17 | 2016 |
| A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. Nat. Commun. 9, 1837 A Roth, SP Maher, AJ Conway, R Ubalee, V Chaumeau, C Andolina, ... This work reports an in vitro hepatocyte system to allow screening for drugs …, 2018 | 16 | 2018 |
| Experimental evaluation of cryopreservative solutions to maintain in vitro and in vivo infectivity of P. berghei sporozoites N Singh, SJ Barnes, S Kennedy, JH Adams PLoS One 12 (5), e0177304, 2017 | 9 | 2017 |
| Variable immunogenicity of a vivax malaria blood-stage vaccine candidate SL De, S May, K Shah, M Slawinski, S Changrob, S Xu, SJ Barnes, ... Vaccine 39 (19), 2668-2675, 2021 | 6 | 2021 |
| A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. Nat Commun. 2018; 9: 1837 A Roth, SP Maher, AJ Conway, R Ubalee, V Chaumeau, C Andolina, ... Epub 2018/05/11. PubMed PMID: 29743474, 0 | 5 | |
| Synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein JH Adams, FB Ntumngia, JL Schloegel, SJ Barnes, AM McHenry, ... US Patent 8,784,832, 2014 | 3 | 2014 |
| Synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein JH Adams, FB Ntumngia, JL Schloegel, SJ Barnes, AM McHenry, ... US Patent 8,784,832, 2014 | 3 | 2014 |
